You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR CASPOFUNGIN ACETATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CASPOFUNGIN ACETATE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00008359 ↗	Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment	Completed	National Cancer Institute (NCI)	Phase 3	2000-08-01	RATIONALE: Caspofungin acetate or amphotericin B liposomal may be effective in preventing or controlling fever and neutropenia caused by chemotherapy, bone marrow transplantation, or peripheral stem cell transplantation. It is not yet known whether caspofungin acetate or amphotericin B liposomal is more effective for treating these side effects. PURPOSE: Randomized phase III trial to compare the effectiveness of caspofungin acetate with that of amphotericin B liposomal in treating patients who have persistent fever and neutropenia after receiving anticancer therapy.
NCT00008359 ↗	Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment	Completed	Memorial Sloan Kettering Cancer Center	Phase 3	2000-08-01	RATIONALE: Caspofungin acetate or amphotericin B liposomal may be effective in preventing or controlling fever and neutropenia caused by chemotherapy, bone marrow transplantation, or peripheral stem cell transplantation. It is not yet known whether caspofungin acetate or amphotericin B liposomal is more effective for treating these side effects. PURPOSE: Randomized phase III trial to compare the effectiveness of caspofungin acetate with that of amphotericin B liposomal in treating patients who have persistent fever and neutropenia after receiving anticancer therapy.
NCT00020527 ↗	Caspofungin Acetate in Treating Children With Fever and Neutropenia	Completed	National Cancer Institute (NCI)	N/A	2001-03-01	RATIONALE: Giving caspofungin acetate may be effective in preventing or controlling fever and neutropenia caused by chemotherapy or bone marrow transplantation. PURPOSE: Clinical trial to study the effectiveness of caspofungin acetate in treating children who have fever and neutropenia caused by a weakened immune system.
NCT00082524 ↗	Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)	Completed	Merck Sharp & Dohme Corp.	Phase 2	2004-04-01	This study is an open label, noncomparative study using an investigational agent for the treatment of documented Candida or Aspergillus infections in pediatric patients (ages 3 months-17 years).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CASPOFUNGIN ACETATE

Condition Name

Chart
Table

Condition Name for CASPOFUNGIN ACETATE
Intervention	Trials
Fungal Infection	8
Candidiasis	4
Neutropenia	3
Leukemia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CASPOFUNGIN ACETATE
Intervention	Trials
Mycoses	11
Neutropenia	7
Candidiasis	7
Infections	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CASPOFUNGIN ACETATE

Trials by Country

Map
Table

Trials by Country for CASPOFUNGIN ACETATE
Location	Trials
United States	77
Canada	10
Spain	5
Germany	2
France	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for CASPOFUNGIN ACETATE
Location	Trials
Tennessee	3
New York	3
Oklahoma	2
Maryland	2
Ohio	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CASPOFUNGIN ACETATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CASPOFUNGIN ACETATE
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	9
Phase 2	8
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CASPOFUNGIN ACETATE
Clinical Trial Phase	Trials
Completed	16
Terminated	2
Not yet recruiting	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CASPOFUNGIN ACETATE

Sponsor Name

Chart
Table

Sponsor Name for CASPOFUNGIN ACETATE
Sponsor	Trials
Merck Sharp & Dohme Corp.	11
National Cancer Institute (NCI)	5
European Organisation for Research and Treatment of Cancer - EORTC	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CASPOFUNGIN ACETATE
Sponsor	Trials
Other	11
Industry	11
NIH	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.